Novo Integrated Sciences ROA 2012-2024 | NVOS

Current and historical return on assets (ROA) values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Novo Integrated Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-08-31 $-0.02B $0.04B -48.92%
2024-05-31 $-0.03B $0.04B -69.93%
2024-02-29 $-0.01B $0.04B -33.33%
2023-11-30 $-0.01B $0.04B -38.62%
2023-08-31 $-0.01B $0.04B -35.62%
2023-05-31 $-0.03B $0.04B -84.77%
2023-02-28 $-0.04B $0.05B -74.87%
2022-11-30 $-0.04B $0.06B -63.35%
2022-08-31 $-0.03B $0.06B -53.44%
2022-05-31 $-0.01B $0.07B -19.40%
2022-02-28 $-0.01B $0.06B -15.13%
2021-11-30 $-0.01B $0.05B -9.85%
2021-08-31 $0.00B $0.04B -9.20%
2021-05-31 $-0.01B $0.04B -16.33%
2021-02-28 $-0.01B $0.04B -16.90%
2020-11-30 $-0.01B $0.04B -16.67%
2020-08-31 $-0.01B $0.04B -14.18%
2020-05-31 $0.00B $0.04B -2.90%
2020-02-29 $0.00B $0.03B -3.01%
2019-11-30 $0.00B $0.03B 0.00%
2019-08-31 $0.00B $0.03B 0.00%
2019-05-31 $0.00B $0.02B 0.00%
2019-02-28 $0.00B $0.01B 0.00%
2018-11-30 $0.00B $0.01B -20.00%
2018-08-31 $0.00B $0.01B -20.00%
2018-05-31 $0.00B $0.01B -38.10%
2018-02-28 $0.00B $0.01B -38.10%
2017-11-30 $0.00B $0.00B -25.00%
2017-08-31 $0.00B $0.00B -36.36%
2017-03-31 $0.00B 0 0.00%
2017-02-28 $0.00B 0 0.00%
2016-11-30 $0.00B 0 0.00%
2016-09-30 $0.00B 0 0.00%
2016-05-31 $0.00B 0 0.00%
2016-03-31 $0.00B 0 0.00%
2015-06-30 $0.00B 0 0.00%
2015-03-31 $0.00B 0 0.00%
2014-06-30 $0.00B 0 0.00%
2014-03-31 $0.00B 0 0.00%
2013-09-30 $0.00B 0 0.00%
2013-06-30 $0.00B 0 0.00%
2012-12-31 $0.00B 0 0.00%
2012-09-30 $0.00B 0 0.00%
2012-03-31 $0.00B 0 0.00%
2012-02-29 $0.00B 0 0.00%
2011-11-30 $0.00B 0 0.00%
2011-09-30 $0.00B 0 0.00%
2011-08-31 $0.00B 0 0.00%
2011-06-30 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
U.S Physical Therapy (USPH) United States $1.157B 29.19
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00